Your session is about to expire
← Back to Search
Oxytocin Nasal Spray for Social Anxiety Disorder
Study Summary
This trial is studying if oxytocin, a hormone and chemical messenger in the brain, can help adults with social anxiety disorder learn safety skills when compared to healthy adults. 120 people will take part at the University of Washington.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2019 Phase 1 & 2 trial • 23 Patients • NCT03119610Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a history of nasal problems.I have never been diagnosed with mania or psychotic disorders.I have no serious illnesses or untreated hormone-related diseases.I am between 18 and 45 years old.I have regular menstrual cycles and do not use oral contraceptives.My primary diagnosis is social anxiety disorder.I am a woman with regular periods and do not use birth control pills.I have never had psychiatric, neurological, or medical disorders.I am currently taking medication for mental health or steroids.I have had a head injury, neurological disorder, or neurosurgery.I am between 18 and 45 years old.This criterion is for individuals who are not currently experiencing any health problems.I have no history of psychiatric, neurological, or medical disorders.I have been diagnosed with social anxiety disorder.
- Group 1: Clinical
- Group 2: Controls
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Who is qualified to participate in this experiment?
"For admittance to this medical trial, volunteers must suffer from social anxiety disorder and be between 18-45 years old. Up to 120 individuals will be accepted into the study."
Are elderly individuals welcome to participate in this research program?
"Eligible candidates for this medical trial should be aged 18 to 45. For those younger than 18 or over 65, there are 13 and 28 trials respectively."
How many individuals are participating in this experiment?
"Affirmative, per the information on clinicaltrials.gov this trial is actively seeking participants. This particular research endeavour was initially posted in late June 2023 and most recently updated at the end of July 2023; with a goal to enroll 120 volunteers from one site."
Has the Clinical product been authorized by the FDA?
"Our evaluation placed the safety of this drug at a 2 due to its Phase 2 status. Although there are data points that attest to safety, efficacy is yet unproven."
Is it currently possible to join this investigation?
"As per clinicaltrials.gov, this research effort is currently looking for enrollees. This trial was made available on June 26th of 2023 and the information was last modified on July 26th of 2023."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger